- Compugen (CGEN -20.5%) plunges after pricing its public offering of 6M shares at $10.50/share, a discount of 26% to yesterday's $14.20 closing price.
- Compugen shares ended last week at $11.60 but surged this week to challenge decade highs; the Israel-based biotech will raise nearly $60M in the offering, but at a punishing price to y new shareholders who bought into this week’s strength.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Fri, 9:57AM)
at CNBC.com (Feb 25, 2014)
at CNBC.com (Sep 3, 2013)
at MarketWatch.com (Aug 5, 2013)
at MarketWatch.com (May 19, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs